EUVIMEDEUVIMED felfedezése
Klinische Studie (Phase I)

Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises – A phase I study

Biju George iD, Rajesh Balakrishnan iD, Patricia S iD, Sharon Lionel iD, Sushil Selvarajan iD, Anup J Devasia iD, Anu Korula iD, Kavitha M Lakshmi, Fouzia N Aboobacker iD, Uday Kulkarni iD, Henry Finlay Godson iD, Jose Solomon Raj iD and 3 more

Clinical Transplantation · 2023

DOI: 10.1111/ctr.15010 ↗

At a glance

Klinische Studie (Phase I) in Clinical Transplantation, 2023. Written by Biju George and 14 co-authors. Institution: Department of Haematology, Christian Medical College, Vellore, India. Major MEDLINE topics: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematopoietic Stem Cell Transplantation, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Graft vs Host Disease. Cited 2 times so far (Crossref); 27 references.

AbsztraktSubjectsBibliográfiai adatokCiteRelated studies

Abstract (original language)

INTRODUCTION: Total marrow lymphoid irradiation (TMLI) can deliver higher doses of irradiation without increasing toxicity compared to Total body irradiation (TBI). METHODS: Twenty adult patients undergoing hematopoietic stem cell transplantation (HSCT) for acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia with lymphoid blast crises (CML-LBC) received TMLI and cyclophosphamide for conditioning. Ten patients each received 13.5 or 15 Gy of TMLI. The graft source was peripheral blood stem cells in all, and donors included matched related (n = 15), haplo-identical (n = 3) or matched unrelated donors (n = 2). RESULTS: The median cell dose infused was 9 × 106 CD34/kg (range 4.8-12.4). Engraftment occurred in all (100%) at a median of 15 days (range: 14-17). Toxicity was low with hemorrhagic cystitis seen in two but no sinusoidal obstruction syndrome. Acute GVHD occurred in 40% while chronic GVHD was seen in 70.5%. Viral infections were seen in 55% while blood stream bacterial infections occurred in 20% and invasive fungal disease (IFD) in 10%. The Day 100 non-relapse mortality (NRM) was 10%. At a median follow up of 25 months (range 2-48), two patients have relapsed. Overall survival at 2 years is 80% while the disease-free survival is 75%. CONCLUSIONS: The combination of TMLI and cyclophosphamide for myeloablative conditioning is associated with low toxicity and favorable early outcomes in patients undergoing HSCT for ALL and CML-LBC.

Subjects

MeSH terms (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveHematopoietic Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Host DiseaseLeukemia, Myeloid, AcuteAdultHumansBone MarrowBlast CrisisLymphatic IrradiationCyclophosphamideChronic DiseaseTransplantation ConditioningRetrospective Studies

Author keywords

HSCTTMLIcyclophosphamideoutcomesphase I studytoxicity

Substances

Cyclophosphamide

Authors and institutions

  • Department of Haematology, Christian Medical College, Vellore, India.
  • Department of Radiation Therapy, Christian Medical College, Vellore, India.

ORCID profiles: Biju George, Rajesh Balakrishnan, Patricia S, Sharon Lionel, Sushil Selvarajan, Anup J Devasia, Anu Korula, Fouzia N Aboobacker, Uday Kulkarni, Henry Finlay Godson, Jose Solomon Raj, Aby Abraham, Selvamani Backianathan, Vikram Mathews

Cite

APA

George, B., Balakrishnan, R., S, P., Lionel, S., Selvarajan, S., Devasia, A. J., Korula, A., Lakshmi, K. M., Aboobacker, F. N., Kulkarni, U., Godson, H. F., Raj, J. S., Abraham, A., Backianathan, S., & Mathews, V. (2023). Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises – A phase I study. Clinical Transplantation. https://doi.org/10.1111/ctr.15010

Vancouver

George B, Balakrishnan R, S P, Lionel S, Selvarajan S, Devasia AJ, et al. Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises – A phase I study. Clinical Transplantation. 2023. doi:10.1111/ctr.15010

BibTeX
@article{George2023,
  author = {George, Biju and Balakrishnan, Rajesh and S, Patricia and Lionel, Sharon and Selvarajan, Sushil and Devasia, Anup J and Korula, Anu and Lakshmi, Kavitha M and Aboobacker, Fouzia N and Kulkarni, Uday and Godson, Henry Finlay and Raj, Jose Solomon and Abraham, Aby and Backianathan, Selvamani and Mathews, Vikram},
  title = {Total marrow lymphoid irradiation and cyclophosphamide is associated with low toxicity and good outcomes in patients undergoing hematopoietic stem cell transplantation for acute lymphoblastic leukemia and chronic myeloid leukemia in lymphoid blast crises – A phase I study},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.15010}
}
Start for free →